Fennec Pharmaceuticals (FRX) Insider Trading & Ownership C$9.04 0.00 (0.00%) As of 05/9/2025 Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Fennec Pharmaceuticals (TSE:FRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage16.20%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)C$157,867.93Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)C$345,297.23 Get FRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Fennec Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address FRX Insider Buying and Selling by Quarter Fennec Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/11/2025Chris Anigeron RallisDirectorSell1,409C$6.93C$9,764.374/4/2025Rostislav Christov RaykovDirectorSell10,000C$7.46C$74,550.003/5/2025Rostislav Christov RaykovDirectorSell7,569C$9.71C$73,503.542/14/2025Chris Anigeron RallisDirectorSell1,186C$9.68C$11,485.702/5/2025Rostislav Christov RaykovDirectorSell2,431C$9.66C$23,476.171/6/2025Rostislav Christov RaykovDirectorSell10,000C$8.76C$87,552.0012/20/2024Rostislav Christov RaykovDirectorBuy25,000C$3.87C$96,840.0012/5/2024Rostislav Christov RaykovDirectorBuy796C$8.52C$6,779.0511/18/2024Robert Christopher AndradeSenior OfficerBuy15,816C$3.43C$54,248.8810/8/2024Chris Anigeron RallisDirectorSell1,406C$6.16C$8,662.08 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/2/2024Rostislav Christov RaykovDirectorSell2,431C$6.67C$16,212.349/4/2024Rostislav Christov RaykovDirectorSell2,431C$7.45C$18,115.817/5/2024Chris Anigeron RallisDirectorSell1,173C$6.03C$7,073.197/1/2024Rostislav Christov RaykovDirectorSell2,431C$6.13C$14,902.03 (Data available from 1/1/2013 forward) FRX Insider Trading Activity - Frequently Asked Questions Who is on Fennec Pharmaceuticals's Insider Roster? The list of insiders at Fennec Pharmaceuticals includes Adrian J. Haigh, Chris Anigeron Rallis, Khalid Islam, Robert Christopher Andrade, and Rostislav Christov Raykov. Learn more on insiders at FRX. What percentage of Fennec Pharmaceuticals stock is owned by insiders? 16.20% of Fennec Pharmaceuticals stock is owned by insiders. Learn more on FRX's insider holdings. Which Fennec Pharmaceuticals insiders have been buying company stock? The following insiders have purchased FRX shares in the last 24 months: Adrian J. Haigh (C$51,332.82), Khalid Islam (C$50,000.48), Robert Christopher Andrade (C$54,248.88), and Rostislav Christov Raykov (C$222,539.92). How much insider buying is happening at Fennec Pharmaceuticals? Insiders have purchased a total of 159,119 FRX shares in the last 24 months for a total of C$378,122.10 bought. Which Fennec Pharmaceuticals insiders have been selling company stock? The following insiders have sold FRX shares in the last 24 months: Adrian J. Haigh (C$207,029.47), Chris Anigeron Rallis (C$70,755.17), Robert Christopher Andrade (C$152,345.67), and Rostislav Christov Raykov (C$308,311.89). How much insider selling is happening at Fennec Pharmaceuticals? Insiders have sold a total of 81,848 Fennec Pharmaceuticals shares in the last 24 months for a total of C$738,442.20 sold. Fennec Pharmaceuticals Key ExecutivesMr. Rostislav Raykov (Age 48)CEO & Director Compensation: $1.2MMr. Robert C. Andrade (Age 49)Chief Financial Officer Compensation: $817.74kMr. Adrian J. Haigh (Age 65)Chief Operating Officer Compensation: $886.92kMr. Mark GowlandControllerMr. Lei FangPresident of Pharstat Inc More Insider Trading Tools from MarketBeat Related Companies APM Insider Buying GXE Insider Buying CRDL Insider Buying MDNA Insider Buying CGC Insider Buying RGC Insider Buying ASND Insider Buying NBY Insider Buying GRI Insider Buying PBM Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You? This page (TSE:FRX) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredVanishing BenefitsWhat would you do if your next Social Security check simply never arrived? If you called and the line was d...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FRX Stock Free FRX Stock Alerts